Bond for Life

The race to develop the next new drug drives pharmaceutical and biotechnology companies and their scientists to stay up-to-date on all the latest research and technology. That’s why ACS publications are a must-read among professionals working to better understand molecular structure and biological activity.

With more than 7.5 million annual home page views, the ACS collection of pharmaceutical and life science-related publications is already capturing the attention of your target audience. More than 50% of readers hold doctorates in their respective fields, and more than 86% of readers hold purchasing power. And you can bond with them, with an effective ACS digital strategy customized to meet your needs.

Target Your Audience

  • More than 100,000 eTOC alert subscribers
  • Delivering over 7 million impressions monthly
  • 52% of readers hold a doctorate or post doctoral
  • 43% of readers plan to purchase chromatography products in the
    next 12 months
  • 67% of readers work in R&D
  • 46% of C&EN readers work in the pharmaceutical and life sciences industries
  • Average Budget: $212,000
  • 51% Industry vs 49% Academic

  • Learn more about our Life Sciences audience.

piegraph-pharma